187 related articles for article (PubMed ID: 37006287)
1. Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification.
Peng Z; Wang J; Tong S; Wu Y; Yi D; Xiang W
Front Immunol; 2023; 14():1128151. PubMed ID: 37006287
[TBL] [Abstract][Full Text] [Related]
2. Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer.
Chen P; Xu J; Cui Z; Wu S; Xie T; Zhang X
Front Immunol; 2023; 14():1071675. PubMed ID: 36761737
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-induced expression of phosducin-like 3 regulates expression of VEGFR-2 and promotes angiogenesis.
Srinivasan S; Chitalia V; Meyer RD; Hartsough E; Mehta M; Harrold I; Anderson N; Feng H; Smith LE; Jiang Y; Costello CE; Rahimi N
Angiogenesis; 2015 Oct; 18(4):449-62. PubMed ID: 26059764
[TBL] [Abstract][Full Text] [Related]
4. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
Zhao WJ; Ou GY; Lin WW
Front Immunol; 2021; 12():682415. PubMed ID: 34054873
[TBL] [Abstract][Full Text] [Related]
5. LncRNA RP3-525N10.2-NFKB1-PROS1 triplet-mediated low PROS1 expression is an onco-immunological biomarker in low-grade gliomas: a pan-cancer analysis with experimental verification.
Zhou Y; Xiao D; Jiang X
J Transl Med; 2022 Jul; 20(1):335. PubMed ID: 35879775
[TBL] [Abstract][Full Text] [Related]
6. Liquid-liquid phase separation-related gene in gliomas: FABP5 is a potential prognostic marker.
Tang Q; Mao X; Chen Z; Ma C; Tu Y; Zhu Q; Lu J; Wang Z; Zhang Q; Wu W
J Gene Med; 2023 Oct; 25(10):e3517. PubMed ID: 37114595
[TBL] [Abstract][Full Text] [Related]
7. Development of a prognostic index based on immunogenomic landscape analysis in glioma.
Luo H; Tao C; Wang P; Li J; Huang K; Zhu X
Immun Inflamm Dis; 2021 Jun; 9(2):467-479. PubMed ID: 33503296
[TBL] [Abstract][Full Text] [Related]
8. TRIM56: a promising prognostic immune biomarker for glioma revealed by pan-cancer and single-cell analysis.
Wang B; Wang Z; Li Y; Shang Z; Liu Z; Fan H; Zhan R; Xin T
Front Immunol; 2024; 15():1327898. PubMed ID: 38348047
[TBL] [Abstract][Full Text] [Related]
9. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
Liu J; Xu K; Ma L; Wang Y
Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
[TBL] [Abstract][Full Text] [Related]
10.
Qu S; Liu J; Wang H
Front Immunol; 2021; 12():648416. PubMed ID: 33889156
[TBL] [Abstract][Full Text] [Related]
11. An immune-related multi-omics analysis of dolichyl-diphosphooligosaccharide protein glycosyltransferase in glioma: Prognostic value exploration and competitive endogenous RNA network identification.
Liu J; Feng C; Liu M; Zhou Y; Shen Y; Li J; Wei X
IET Syst Biol; 2023 Oct; 17(5):271-287. PubMed ID: 37606290
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen Activator Urokinase Receptor Implies Immunosuppressive Features and Acts as an Unfavorable Prognostic Biomarker in Glioma.
Zeng F; Li G; Liu X; Zhang K; Huang H; Jiang T; Zhang Y
Oncologist; 2021 Aug; 26(8):e1460-e1469. PubMed ID: 33687124
[TBL] [Abstract][Full Text] [Related]
13. Pan-cancer analysis reveals NUP37 as a prognostic biomarker correlated with the immunosuppressive microenvironment in glioma.
He Y; Li J; Shen L; Zhou H; Fei W; Zhang G; Li Z; Wang F; Wen Y
Aging (Albany NY); 2022 Jan; 14(2):1033-1047. PubMed ID: 35093934
[TBL] [Abstract][Full Text] [Related]
14. Prognosis prediction and tumor immune microenvironment characterization based on tryptophan metabolism-related genes signature in brain glioma.
Zhang S; Chen S; Wang Z; Li J; Yuan Y; Feng W; Li W; Chen M; Liu Y
Front Pharmacol; 2022; 13():1061597. PubMed ID: 36386216
[TBL] [Abstract][Full Text] [Related]
15. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
Wang Y; Zhao W; Liu X; Guan G; Zhuang M
J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
[TBL] [Abstract][Full Text] [Related]
16. ABCD3 is a prognostic biomarker for glioma and associated with immune infiltration: A study based on oncolysis of gliomas.
Li J; Zhang Y; Qu Z; Ding R; Yin X
Front Cell Infect Microbiol; 2022; 12():956801. PubMed ID: 35959373
[TBL] [Abstract][Full Text] [Related]
17. Purine metabolism-related gene expression signature predicts survival outcome and indicates immune microenvironment profile of gliomas.
Chen S; Zhang S; Wang Z; Li J; Yuan Y; Li T; Zuo M; Feng W; Li W; Chen M; Liu Y
Front Pharmacol; 2022; 13():1038272. PubMed ID: 36438805
[TBL] [Abstract][Full Text] [Related]
18. Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma.
Xu L; Shao F; Luo T; Li Q; Tan D; Tan Y
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955624
[TBL] [Abstract][Full Text] [Related]
19. TNFSF13 Is a Novel Onco-Inflammatory Marker and Correlates With Immune Infiltration in Gliomas.
Chen R; Wang X; Dai Z; Wang Z; Wu W; Hu Z; Zhang X; Liu Z; Zhang H; Cheng Q
Front Immunol; 2021; 12():713757. PubMed ID: 34712225
[TBL] [Abstract][Full Text] [Related]
20. MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma.
Sun JZ; Zhang JH; Li JB; Yuan F; Tong LQ; Wang XY; Chen LL; Fan XG; Zhang YM; Ren X; Zhang C; Yu SP; Yang XJ
Dis Markers; 2021; 2021():6680883. PubMed ID: 34211612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
